☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Novavax
Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US
September 2, 2024
Novavax’s Nuvaxovid Receives EC’s Marketing Authorization for the Prevention of COVID-19
July 7, 2023
PharmaShots Weekly Snapshots (January 02 - 06, 2023)
January 6, 2023
Novavax Initiates P-II Trial of COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
January 2, 2023
Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada
November 21, 2022
Novavax’s Nuvaxovid (NVX-CoV2373) Booster Dose Receives the MHRA Recommendation for Expanded Conditional Marketing Authorization t...
November 10, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.